Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5776836

O=C(CCc1cnoc1-c1ccc(F)cc1)N1CCN(c2ccccc2Cl)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.44
KMT2A Q03164 4/20 0.43
GFER P55789 1/20 0.43
HTR7 P34969 1/20 0.43
MC4R P32245 3/20 0.42
TSHR P16473 2/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 3/20 0.42
TP53 P04637 2/20 0.42
SCD O00767 1/20 0.41
SCD5 Q86SK9 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5775321 0.92 KMT2A (0.53) KMT2AGFERTSHRMAPTMEN1
Trifluoroacetic Acid SCHEMBL5775195 0.90 ATM (0.49) KMT2AGFERMAPTTP53ADAMTS5
Trifluoroacetic Acid SCHEMBL5772610 0.89 GFER (0.53) PARP1KMT2AGFERTSHRMAPT
Trifluoroacetic Acid SCHEMBL5777370 0.89 L3MBTL1 (0.55) KMT2AHTR7TSHRMAPTMEN1
Trifluoroacetic Acid SCHEMBL5770010 0.88 HTR1A (0.49) KMT2AHTR7TSHRMAPTMEN1
Trifluoroacetic Acid SCHEMBL5777433 0.87 GFER (0.53) PARP1KMT2AGFERTSHRMAPT
Trifluoroacetic Acid SCHEMBL5774077 0.87 POLB (0.51) PARP1KMT2AGFERHTR7MAPT
Trifluoroacetic Acid SCHEMBL5776129 0.86 MEN1 (0.50) KMT2AGFERHTR7TSHRMAPT
Trifluoroacetic Acid SCHEMBL5776822 0.86 DPP8 (0.50) KMT2AGFERTSHRMAPTMEN1
Trifluoroacetic Acid SCHEMBL5776691 0.86 GRM5 (0.48) GFERHTR7TSHRMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR PARP1 4263/4885KMT2A 3907/4885GFER 811/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 PARP1 3102/4885KMT2A 2906/4885GFER 1403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.